The Centers for Disease Control and Prevention plans to ramp up the number of SARS-CoV-2 samples that are sequenced in the US, CNN reports.
CNN adds that the US has been criticized for its limited SARS-CoV-2 sequencing. It notes, for instance, that the US has contributed 57,000 SARS-CoV-2 sequences to the GISAID database, while the UK has submitted 141,000 sequences.